Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(5 sites)
United States
University of Michigan Hospitals, Ann Arbor, Michigan Case Comprehensive Cancer Center, Cleveland, Ohio Oregon Health & Science University, Portland, Oregon The University of Texas MD Anderson Cancer Center, Houston, Texas NEXT Virginia, Fairfax, Virginia